Article in Molecular carcinogenesis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors at 2 institutions in 2 countries.
Josien C A JenniskensDepartment of Epidemiology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, The Netherlands.ORCID 0000-0003-2727-2981
Kelly OffermansDepartment of Epidemiology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, The Netherlands.ORCID 0000-0001-6842-4887
Colinda C J M SimonsDepartment of Epidemiology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, The Netherlands.ORCID 0000-0002-0085-5186
Iryna SamarskaDepartment of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, The Netherlands.ORCID 0000-0003-4092-0672
Gregorio E FazziDepartment of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, The Netherlands.ORCID 0000-0001-7068-8435
Jaleesa R M van der MeerDepartment of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, The Netherlands.
Kim M SmitsDepartment of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, The Netherlands.ORCID 0000-0002-4629-4396
Leo J SchoutenDepartment of Epidemiology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, The Netherlands.ORCID 0000-0003-3361-7560
Matty P WeijenbergDepartment of Epidemiology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, The Netherlands.ORCID 0000-0003-1695-4768
Heike I GrabschDepartment of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, The Netherlands.ORCID 0000-0001-9520-6228
Piet A van den BrandtDepartment of Epidemiology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, The Netherlands.ORCID 0000-0001-8781-8099
Maastricht University · NLUniversity of Leeds · GB
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
KRAS mutations (KRAS
Indexed as
Colonic NeoplasmsColorectal NeoplasmsDNA Mismatch RepairRectal NeoplasmsAdolescentAdultChildClass I Phosphatidylinositol 3-KinasesCohort StudiesFemaleHumansMaleMutationProto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)Young AdultBRAF protein, humanClass I Phosphatidylinositol 3-KinasesKRAS protein, humanPIK3CA protein, humanProto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)colorectal cancerearly-life energy balancemismatch repair/microsatellite instabilitymutationsprospective cohort study
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Energy balance-related factors in childhood and adolescence and risk of colorectal cancer based on KRAS, PIK3CA, and BRAF mutations and MMR status. · full record | OpenQuestion